SCHEMBL23944722

SCHEMBL23944722

c1ccc2cc(-c3nc(-c4cc5ccccc5c5ccccc45)nc(-c4cncc5oc6cc7ccccc7cc6c45)n3)ccc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 6/20 0.37
CYP11B2 P19099 5/20 0.37
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
KDM4E B2RXH2 3/20 0.34
PRKCZ Q05513 2/20 0.34
ERN1 O75460 1/20 0.33
ALDH1A1 P00352 4/20 0.33
HSD17B10 Q99714 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
TSHR P16473 2/20 0.33
TP53 P04637 2/20 0.33
MAPK9 P45984 2/20 0.33
MAPK10 P53779 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23944929 0.93 KDM4E (0.39) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL24762334 0.92 CYP11B1 (0.40) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL25508737 0.92 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL23944361 0.90 CYP1A2 (0.36) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL24762187 0.90 KDM4E (0.41) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL23944559 0.88 KDM4E (0.40) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL25465644 0.88 CYP1A1 (0.40) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL24762329 0.88 CYP11B1 (0.36) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL23944537 0.87 KDM4E (0.39) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9
SCHEMBL25509112 0.87 CYP11B1 (0.38) CYP11B1CYP11B2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2022-12-22 US disclosed
WO-2021210910-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, CRY1, CRY2 CYP11B1 546/4885CYP11B2 706/4885CYP1A2 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.